Arena Pharmaceuticals Inc.
ARNA
NGS
Sector: Healthcare
Industry: Biotechnology
99.99
USD
0.00
(0.00%)
Optionable: Yes Market Cap: 6,165 M 90-day average vol: 1,710,994
Previous close: 99.99 Open: 0.0 Bid: Ask:
52 week range
45.50 100.00
Last updated: Friday 20th May 2022
Valuation
Price per Sales TTM ($) | 114,172.63 |
Price per Book TTM ($) | 9.16 |
PE Ratio (TTM) | -9.90 |
Book Value per Share ($) | 13.06 |
5 Year PE Range-58.2 |
Returns
7 Day Return | 0.00% | |
1 Month Return | 0.00% | |
3 Month Return | 7.37% | |
1 Year Return | 63.57% | |
3 Year Return | 86.90% | |
5 Year Return | 646.19% | |
YTD Return | 7.59% |
Risk
Custom Beta One Year | 0.00 |
Custom Beta Three Years | 0.00 |
Beneish M Score | -110.55 |
Altman Z Score | 30.10 |
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 78.91 |
14 Day SMA ($) | 96.21 |
14 Day EMA ($) | 96.90 |
Money Flow Index | 47.48 |
Average True Range | 14.78 |
50 Day SMA ($) | 93.49 |
200 Day SMA ($) | 70.42 |
ADX | 29.83 |
MACD | 2.07 |
Growth
Free Cash Flow QoQ Growth | -35.57% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | -20.87% |
Revenue QoQ Growth | 0.00% |
EPS YoY Growth | 0.00% |
Profitability
Top Marijuana Stocks on the Nasdaq for March 2022
Yahoo Finance 3/2/2022
Top Marijuana Stocks for March 2022
Yahoo Finance 2/28/2022
Arena (ARNA) Q4 Loss Wider Than Expected, Etrasimod in Focus
Yahoo Finance 2/24/2022
Arena Pharmaceuticals GAAP EPS of -$2.54 misses by $0.31
Seeking Alpha 2/23/2022
Arena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates
Yahoo Finance 2/23/2022
SFO opens criminal probe into collapse of Arena Television
Yahoo Finance 2/23/2022
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance 2/17/2022
Arena Pharmaceuticals to Release Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update on February 23
Yahoo Finance 2/9/2022
Alpine Associates Management Inc. Buys Cerner Corp, Kirkland Lake Gold, Rogers Corp, Sells , ,
Yahoo Finance 2/8/2022
Versor Investments LP Buys Cerner Corp, Ortho Clinical Diagnostics Holdings PLC, Vonage ...
Yahoo Finance 2/8/2022
Did The Smart Money Play Arena Pharmaceuticals, Inc. (ARNA) Correctly?
Yahoo Finance 2/6/2022
Integral Health Asset Management, LLC Buys McKesson Corp, Centene Corp, Abbott Laboratories, ...
Yahoo Finance 2/2/2022
One of the largest biotech ETFs has the second highest short interest float of U.S. ETFs
Seeking Alpha 1/31/2022
Havens Advisors Llc Buys BHP Group PLC, CyrusOne Inc, NeoPhotonics Corp, Sells , ,
Yahoo Finance 1/31/2022
| NA |
|---|
| could not broadcast input array from shape (20) into shape (0) |
|---|
ARNA Income Statement
Annual
| Dec-12 | Dec-13 | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 28 M | 81 M | 37 M | 13 M | 92 M | 21 M | 18 M | 806 M | 319000 |
| Cost of sales | -6 M | -2 M | -1 M | 8 M | 10 M | 5 M | -3 M | 2 M | -5 M |
| Gross operating profit | 24 M | 75 M | 29 M | 223000 | 77 M | 12 M | 18 M | 806 M | 319000 |
| Selling Gen & administrative expense | 26 M | 32 M | 34 M | 30 M | 28 M | 30 M | 48 M | 92 M | 103 M |
| Research & development expense | 54 M | 66 M | 100 M | 83 M | 64 M | 71 M | 115 M | 231 M | 324 M |
| Operating income | -57 M | -23 M | -105 M | -100 M | 881000 | -80 M | -145 M | 483 M | -427 M |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income net | -19 M | 11 M | 52 M | -4 M | -7 M | -10 M | 3 M | 3 M | 15 M |
| Pre-tax Income (EBT) | -85 M | -19 M | -60 M | -111 M | -12 M | -96 M | -139 M | 508 M | -405 M |
| Income taxes | 0 | 0 | 0 | 0 | 0 | 0 | -110 M | 110 M | 0 |
| Net income from total operations | -85 M | -19 M | -60 M | -108 M | -23 M | -93 M | -29 M | 398 M | -405 M |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total net income | -85 M | -19 M | -61 M | -108 M | -23 M | -91 M | -29 M | 398 M | -405 M |
| Preferred dividends | 3 M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net income available for common | -88 M | -19 M | -60 M | -111 M | -12 M | -96 M | -29 M | 398 M | -405 M |
| Depreciation | 10 M | 8 M | 9 M | 5 M | 5 M | 4 M | 3 M | -2 M | 5 M |
| Amortization | 691000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income before depreciation (EBITDA) | -47 M | -15 M | -96 M | -95 M | 6 M | -76 M | -141 M | 486 M | -396 M |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic EPS total | -4.5 | -0.9 | -2.8 | -4.5 | -0.9 | -2.77 | -0.63 | 7.99 | -7.39 |
| Diluted EPS total | -4.5 | -0.9 | -2.8 | -4.5 | -0.9 | -2.77 | -0.63 | 7.69 | -7.39 |
Top MarketXLS Rank stocks
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!